Reviews rolling in for new Apple Watch, ECG app

The reviews are beginning to roll in for the new Apple Watch Series 4, which features an application that allows users to take their own electrocardiogram (ECG) reading.

Apple introduced its latest watch during an event on Sept. 12 in Cupertino, California. Among its many features, the fourth-generation watch is 30 percent larger, has an extended battery life and an FDA-approved ECG app.

Below are several reviews about Apple’s latest watch and its ECG feature.

In a New York Times review of the watch, technology writer Brian Chen said though the ECG feature isn’t as comprehensive as a traditional electrocardiograph, it’s helpful for people with heart problems.

“The new Apple Watch is perhaps one of the most significant developments in wearable gadgets in years. People with heart problems can easily use the EKG app to take electrocardiograms whenever they sense something abnormal, without the rigmarole I went through,” Chen wrote. “And the data can be shared immediately with their doctor, which could open a conversation about next steps, like going in for a visit or modifying treatment.”

A review in Women’s Health magazine said the “heart rate sensor functionality is legit.”

“Roughly a year and a half in the making, this ECG functionality is approved by the American Heart Association as well as the Food and Drug Administration, which is a very big deal,” the report said.

In a USA Today review, tech columnist Edward Baig wondered how people would respond to the new app.

“I question how this will work with real people in the real world. Will there be a high incidence of false positives? Will consumers even understand the results? The onus is on Apple to make this simple and to explain it in terms that won't freak watch wearers out,” Baig wrote.

""

Danielle covers Clinical Innovation & Technology as a senior news writer for TriMed Media. Previously, she worked as a news reporter in northeast Missouri and earned a journalism degree from the University of Illinois at Urbana-Champaign. She's also a huge fan of the Chicago Cubs, Bears and Bulls. 

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”